Adaptive Biotechnologies issues 0% convertible senior notes due 2031
Adaptive Biotechnologies Corporation entered into an indenture with U.S. Bank Trust Company for 0% convertible senior notes due 2031, dated June 22, 2026. This debt offering provides the company with capital financing while offering investors conversion rights to equity.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day